Ascendia

  MARKET NEWS

Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO 
Vandria Reports Positive Phase 1 Target Engagement Data for VNA-318, Supporting Further Development in Alzheimer’s Disease
Bayer Starts New Phase III Study with Mirena for the Treatment of Nonatypical Endometrial Hyperplasia
NorthX Biologics Achieves Milestone GMP Certification to Manufacture Mendus’ Lead Cell Therapy Product for Acute & Chronic Myeloid Leukemias
Belite Bio Announces Positive Topline Results From Pivotal Global Phase 3 of Tinlarebant in Adolescents With Stargardt Disease
Croda Expands Biopharma Capabilities Through Strategic Partnership
Sever Pharma Solutions Appoints Linda Rebert as VP Operations
Bracco, Limula & University of Fribourg Join Forces to Improve Cell & Gene Therapy Manufacturing
Amphista Therapeutics Announces New AMX-883 Data to be Presented & Provides a Business Progress Update
Kymera Therapeutics Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of  a First-in-Class, Oral STAT6 Degrader

  EXPERT CONTENT & RESOURCES

CAPMUL GDO (Glycerol Dioleate) is a Versatile Excipient for Pharmaceutical Formulations

CAPMUL GDO (Glycerol Dioleate) is a Versatile Excipient for Pharmaceutical Formulations

ABITEC is excited to present its latest excipient, CAPMUL GDO, Glycerol Dioleate.  CAPMUL GDO is a high-purity, highly versatile functional lipid

To Improve Upon a Miracle Drug: Overcoming Drug Resistance & Intolerance in CML

To Improve Upon a Miracle Drug: Overcoming Drug Resistance & Intolerance in CML

Thanks to the pioneering work of researchers advancing our knowledge of basic science and cancer, the field has been able to transform the lives of millions of patients with CML. But challenges remain, and everyone in the industry strives to improve upon the “miracle drug” imatinib, that was approved almost 25 years ago.

From Concept to Optimization: A Step-by-Step Guide to SEDDS for Enhanced Oral Bioavailability

From Concept to Optimization: A Step-by-Step Guide to SEDDS for Enhanced Oral Bioavailability

Join Dr. Masumi Dave, Application Lab Manager at Gattefossé USA, for a practical, step-by-step guide to developing optimized Self-Emulsifying Drug Delivery Systems (SEDDS). This webinar provides a proven framework you can apply in your lab to overcome solubility and permeability challenges with lipid excipients.

  FEATURED EDITORIAL

  COMPANY PROFILE

Medbio is a medical manufacturing partner like no other, with the broadest spectrum of medical molding solutions. From precision custom molding capabilities, full-service manufacturing and value-added assembly to a wide range of standard protective parts, medical packaging and labware components, Medbio is the one partner you need. Click here for more.

  WHITEPAPERS & WEBINARS

WEBINAR ON DEMAND: Advantages of Carbopol® Polymers in Oral Formulations

WEBINAR ON DEMAND: Advantages of Carbopol® Polymers in Oral Formulations

In this video, the Lubrizol team together with the IMCD US team takes you through formulation aspects of Carbopol® polymers as well as the results of a case study on an Acetaminophen oral suspension formulation.

ON-DEMAND WEBINAR – Solve Common Design Challenges in Inhalation Devices With Porous Polymers

ON-DEMAND WEBINAR – Solve Common Design Challenges in Inhalation Devices With Porous Polymers

The effectiveness of inhalation devices relies on their ability to deliver the pharmaceutical directly to the targeted part of the body with precision and calculated dosing.  Since these devices….

ON-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules

ON-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules

In this talk we illustrate several case studies demonstrating how a fundamental understanding of molecular properties combined with a strategic vision for drug product design can lead to effective and advanceable formulations for even the most challenging drug products.

  WHITEPAPERS & WEBINARS

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

It is widely reported that 40% of New Chemical Entities (NCEs) in the pharmaceutical industry are poorly soluble, leading to inadequate bioavailablity. Spray drying is one of the most promising particle engineering technologies used to overcome solubility issues in active …

WHITEPAPER - Continuous Flow - An Emerging Alternative

WHITEPAPER - Continuous Flow - An Emerging Alternative

Pharmaceutical companies have traditionally been risk-averse, often adopting safe and well-established processes due to the conservative stance of regulatory agencies on novel methodologies. However, with the increasing complexity of drug molecules and the demand for newer and harsher reaction conditions, …

WHITEPAPER - Advancements in Intradermal Delivery: From Historic Techniques to Modern Innovations

WHITEPAPER - Advancements in Intradermal Delivery: From Historic Techniques to Modern Innovations

Abstract

Intradermal delivery has long been a critical method in medical and pharmaceutical fields, offering unique advantages for diagnosis, vaccination and therapeutic applications. This white paper explores the evolution of intradermal delivery methods, comparing historic methods of delivery such as …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

December 10 – ODT/Fast Dissolve
December 17 – Lyophilization Manufacturing